Pilot Study of Ketamine in Adults With Obsessive-Compulsive Disorder (OCD)

Completed · Phase 2

Conditions studied: Obsessive-Compulsive Disorder

In brief

In this study investigators are studying the effects of a drug called ketamine on the symptoms of Obsessive-compulsive disorder (OCD).

Key facts

Study ID

NCT01100255

Run by

New York State Psychiatric Institute

People needed

15

Starts

2010-04-01

Expected to finish

2015-12-01

Last updated by the study team

2017-02-20

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18-55
• Physically healthy and not currently pregnant
• Primary Diagnosis of OCD
• Sufficient severity of symptoms
• Able to provide consent

You may not qualify if…

• Psychiatric conditions that make participation unsafe
• Currently on psychotropic medication
• Medical conditions that make participation unsafe
• Allergy to ketamine
• Any metal in the body

Where it is running

• New York State Psychiatric Institute — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.